Edesa Biotech (EDSA) News Today → New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad) Free EDSA Stock Alerts $4.35 -0.05 (-1.14%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineInsider Buying: Edesa Biotech, Inc. (NASDAQ:EDSA) CEO Acquires 5,000 Shares of Stockinsidertrades.com - March 26 at 5:00 AMEDSA: Development of EB05 in ARDS Continues…finance.yahoo.com - February 15 at 6:27 PMEdesa Biotech Inc (EDSA)investing.com - February 14 at 8:13 PMEdesa Biotech Stock (NASDAQ:EDSA) Earnings Dates and Earning Callsbenzinga.com - February 11 at 8:13 PMEdesa Biotech Reports Fiscal 1st Quarter 2024 Resultsfinance.yahoo.com - February 9 at 5:04 PMEDSA: Updated Phase 3 Protocol for EB05 Trial Approved by Canadian Regulators…finance.yahoo.com - January 2 at 6:24 PMEdesa Biotech Reports Fiscal Year 2023 Resultsfinance.yahoo.com - December 15 at 5:16 PMmarketbeat.com - December 12 at 12:56 PMEdesa Biotech Stock (NASDAQ:EDSA) Dividends: History, Yield and Datesbenzinga.com - December 1 at 1:28 AMEdesa Biotech Inc EDSAmorningstar.com - November 12 at 11:12 PMEdesa Biotech (EDSA) Price Target Increased by 528.00% to 53.38msn.com - November 2 at 12:56 AMEdesa Biotech to Present at Dermatology Drug Development Summitfinance.yahoo.com - October 26 at 8:03 PMRegulators Approve Updated Phase 3 Trial Design for Edesa Biotech’s ARDS Drugfinance.yahoo.com - October 25 at 1:20 PMEDSA: Secures up to CAD$23 Million to Fund Development of EB05…finance.yahoo.com - October 19 at 2:20 PMmarketbeat.com - October 13 at 9:44 AMWhy Is Infectious Disease Player Edesa Biotech Stock Soaring Today?msn.com - October 12 at 6:25 PMEdesa Biotech to Receive Up To C$23 Million in Funding from Federal Governmentfinance.yahoo.com - October 12 at 1:11 PMEdesa Biotech Secures $10 Million Credit Facility with Company Founderfinance.yahoo.com - October 12 at 1:11 PMmarketbeat.com - October 12 at 12:14 PMEdesa Biotech falls after 1-for-7 reverse stock split announcementseekingalpha.com - October 11 at 4:09 PMEdesa Biotech Falls to 52-Week Low on Reverse Split Newsmarketwatch.com - October 10 at 2:17 PMEdesa Biotech Announces One-for-Seven Reverse Share Splitfinance.yahoo.com - October 10 at 9:17 AMEdesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidatefinance.yahoo.com - September 28 at 12:46 PMEDSA: EB05 Inhibits Inflammation Initiated by Multiple Pathogens In Vitro…finance.yahoo.com - August 16 at 6:40 PMHC Wainwright & Co. Maintains Edesa Biotech (EDSA) Buy Recommendationmsn.com - August 15 at 9:24 PMEdesa Biotech Reports Fiscal Third Quarter 2023 Resultsfinance.yahoo.com - August 9 at 8:30 PMEdesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conferencefinance.yahoo.com - July 27 at 1:10 AMEdesa Biotech's COVID-19 Candidate Restraints Inflammation From Influenza, Other Pathogens In Preclinical Studiesmsn.com - June 28 at 3:19 PMEdesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogensfinance.yahoo.com - June 28 at 10:18 AMEdesa Biotech Anti-Inflammatory Drug Candidate Assigned Namefinance.yahoo.com - June 15 at 9:38 AMHC Wainwright & Co. Reiterates Edesa Biotech (EDSA) Buy Recommendationmsn.com - May 24 at 6:13 PMEdesa Biotech (EDSA) Earnings Dates & Reportsinvesting.com - May 19 at 4:34 PMEDSA: FDA Agrees on Primary Endpoint for Phase 3 ARDS Drug Study…finance.yahoo.com - May 17 at 2:28 PMEdesa Biotech GAAP EPS of -$0.12 beats by $0.05msn.com - May 12 at 12:25 AMEdesa Biotech Reports Fiscal 2nd Quarter 2023 Resultsfinance.yahoo.com - May 11 at 7:24 PMEdesa Biotech to Participate in Swiss Biotech Dayfinance.yahoo.com - April 20 at 10:56 AMEdesa Biotech: The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidatefinanznachrichten.de - April 4 at 10:36 AMThe WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidatefinance.yahoo.com - April 4 at 10:35 AMEdesa Biotech, Inc. (EDSA)uk.finance.yahoo.com - March 25 at 7:52 AMEdesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conferencefinance.yahoo.com - March 23 at 6:31 PMEdesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meetingfinance.yahoo.com - March 16 at 7:07 PMEdesa Biotech Stock (NASDAQ:EDSA), Short Interest Reportbenzinga.com - March 16 at 2:53 AMEdesa Biotech Stock (NASDAQ:EDSA), Guidance and Forecastbenzinga.com - March 16 at 2:53 AMH.C. Wainwright Reaffirms Their Buy Rating on Edesa Biotech (EDSA)markets.businessinsider.com - March 15 at 11:52 AMEdesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Studyfinance.yahoo.com - March 15 at 11:52 AMEDSA: Positive News Flow to Start 2023…finance.yahoo.com - February 15 at 12:55 PMIs Edesa Biotech (NASDAQ:EDSA) In A Good Position To Invest In Growth?finance.yahoo.com - February 12 at 9:26 AMEdesa Biotech earnings beat by $0.02, revenue was in line with estimatesng.investing.com - February 11 at 6:26 PMEdesa Biotech Reports Fiscal 1st Quarter 2023 Resultsfinance.yahoo.com - February 10 at 10:34 AMEdesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Studyfinance.yahoo.com - February 1 at 9:26 AM Get Edesa Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for EDSA and its competitors with MarketBeat's FREE daily newsletter. Email Address New crypto project uncovers 2,050% in 65 days (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. EDSA Media Mentions By Week EDSA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EDSA News Sentiment▼0.000.53▲Average Medical News Sentiment EDSA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EDSA Articles This Week▼00▲EDSA Articles Average Week Get Edesa Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for EDSA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMNN News Today JAN News Today AVTX News Today KPRX News Today MIRA News Today ORGS News Today BNTC News Today RDHL News Today COCP News Today TNXP News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EDSA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edesa Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.